Biodesix, Inc.
BDSX
$15.86
$0.563.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.76% | 19.93% | 11.68% | 21.19% | 39.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.76% | 19.93% | 11.68% | 21.19% | 39.28% |
| Cost of Revenue | 12.37% | -1.75% | 3.97% | 16.63% | 28.69% |
| Gross Profit | 48.42% | 26.41% | 13.80% | 22.43% | 42.44% |
| SG&A Expenses | 13.62% | 8.48% | 13.99% | -0.53% | 24.42% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.89% | 7.74% | 13.86% | 4.85% | 25.38% |
| Operating Income | 69.97% | 18.01% | -18.64% | 17.26% | 4.38% |
| Income Before Tax | 51.76% | 15.03% | -6.11% | 18.46% | 9.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 51.76% | 15.03% | -6.11% | 18.46% | 9.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.76% | 15.03% | -6.11% | 18.46% | 9.72% |
| EBIT | 69.97% | 18.01% | -18.64% | 17.26% | 4.38% |
| EBITDA | 88.64% | 20.59% | -22.18% | 20.04% | 13.15% |
| EPS Basic | 56.16% | 17.13% | 8.00% | 45.94% | 43.14% |
| Normalized Basic EPS | 55.61% | 17.19% | 5.45% | 46.02% | 43.71% |
| EPS Diluted | 56.16% | 17.13% | 8.00% | 45.94% | 43.14% |
| Normalized Diluted EPS | 55.61% | 17.19% | 5.45% | 46.02% | 43.71% |
| Average Basic Shares Outstanding | 10.02% | 2.53% | 15.32% | 50.82% | 58.79% |
| Average Diluted Shares Outstanding | 10.02% | 2.53% | 15.32% | 50.82% | 58.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |